Plus Therapeutics, Inc.

PSTV · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$4$5-$17-$4
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$1-$5-$1$2
Other Non-Cash$1-$7$12$0
Operating Cash Flow-$3-$6-$6-$1
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$3$0$0-$8
Inv. Sales/Matur.$5$3$4$9
Other Inv. Act.$0-$8$0$0
Investing Cash Flow$1-$5$4$0
Financing Activities
Debt Repay.$1$0-$3$0
Stock Issued-$4$0$0$0
Stock Repurch.$0-$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$15$3$16$0
Financing Cash Flow$12$3$12$0
Forex Effect$0$0$0$0
Net Chg. in Cash$11-$8$10-$1
Supplemental Information
Beg. Cash$2$10$0$1
End Cash$13$2$10$0
Free Cash Flow-$3-$6-$6-$1
Plus Therapeutics, Inc. (PSTV) Financial Statements & Key Stats | AlphaPilot